Evidence map›Paper›PMID 32350737›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2020

Emergence of linezolid-resistant Staphylococcus epidermidis in the tertiary children's hospital in Cracow, Poland.

Maja Kosecka-Strojek, Ewa Sadowy, Iwona Gawryszewska, Joanna Klepacka, Tomasz Tomasik, Michal Michalik, Waleria Hryniewicz, Jacek Miedzobrodzki

Open access · hybridAbstract read
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The Opportunistic PathogenAntibiotics (Basel, Switzerland) · 2024
    Review
  8. Article
  9. Article
  10. The Emergence of Linezolid-ResistantIranian journal of medical sciences · 2024
    Article
  11. Investigation of a linezolid-resistantFrontiers in microbiology · 2024
    Article
  12. Antimicrobial Resistance Profiles andClinical, cosmetic and investigational dermatology · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Maja Kosecka-StrojekDepartment of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387, Krakow, Poland.
Ewa SadowyDepartment of Molecular Microbiology, National Medicines Institute, Warsaw, Poland.
Iwona GawryszewskaDepartment of Molecular Microbiology, National Medicines Institute, Warsaw, Poland.
Joanna KlepackaDepartment of Clinical Microbiology, Children's University Hospital, Jagiellonian University, Krakow, Poland.
Tomasz TomasikDepartment of Clinical Microbiology, Children's University Hospital, Jagiellonian University, Krakow, Poland.
Michal MichalikMML Medical Centre, Warsaw, Poland.
Waleria HryniewiczDepartment of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland.
Jacek MiedzobrodzkiDepartment of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387, Krakow, Poland. jacek.miedzobrodzki@uj.edu.pl.
Jagiellonian University · PLNarodowy Instytut Leków · PL

Funding

Narodowym Centrum Nauki UMO-2016/21/N/NZ6/00981
6 · The paper itself

Abstract

Coagulase-negative staphylococci, ubiquitous commensals of human skin, and mucous membranes represent important pathogens for immunocompromised patients and neonates. The increasing antibiotic resistance among Staphylococcus epidermidis is an emerging problem worldwide. In particular, the linezolid-resistant S. epidermidis (LRSE) strains are observed in Europe since 2014. The aim of our study was to genetically characterize 11 LRSE isolates, recovered mostly from blood in the University Children's Hospital in Krakow, Poland, between 2015 and 2017. For identification of the isolates at the species level, we used 16S rRNA sequencing and RFLP of the saoC gene. Isolates were characterized phenotypically by determining their antimicrobial resistance patterns and using molecular methods such as PFGE, MLST, SCCmec typing, detection of the ica operon, and analysis of antimicrobial resistance determinants. All isolates were multidrug-resistant, including resistance to methicillin, and exhibited so-called PhLOPS

Indexed as

Anti-Bacterial AgentsDrug Resistance, Multiple, BacterialFemaleHospitals, PediatricHumansInfantInfant, NewbornLinezolidMaleMicrobial Sensitivity TestsPolandRibosomal Protein L3Staphylococcal InfectionsStaphylococcus epidermidisAnti-Bacterial AgentsLinezolidRibosomal Protein L3RPL3 protein, humanAntibiotic resistanceICUInfectionsStaphylococci

Identifiers

PMID32350737
PMCPMC7427702
OpenAlexW3023614875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.